Ripertamab, CAS 2249927-04-4

Product Description: Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Kaplon H, et al. Antibodies to watch in 2022. MAbs. 2022 Jan-Dec;14(1):2014296.

CAS Number: 2249927-04-4

Molecular Weight: N/A

Research Area: Cancer

Solubility: H2O

Target: CD20

• SKU: MEXHY-P99952-0
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99952-0
• Package Unit: Get quote
• Quantity Unit: STK
• Conjugate: Unconjugated